Chagasic meningoencephalitis with detection of Trypanosoma cruzi in the cerebrospinal fluid of an immunodepressed patient.
We report a case of chagasic meningoencephalitis with the detection of Trypanosoma cruzi in the cerebrospinal fluid (CSF). The patient was a renal transplant recipient with a chagasic history preceding surgery who had been receiving immunosuppressive medication for 8 years, a probable cause of the recrudescence of Chagas' disease. He was treated with benznidazole, with normalization of the CSF. He was discharged from hospital in a good clinical condition.
Jardim
E
E
Department of Neurology, Faculty of Medicine of Ribeirão Preto, São Paulo University, Brazil.
Takayanagui
O M
OM
D000328:Adult; D000818:Animals; D002555:Cerebrospinal Fluid / Q000469:parasitology*; D014355:Chagas Disease / Q000134:cerebrospinal fluid* / Q000188:drug therapy / Q000276:immunology; D006801:Humans; D016867:Immunocompromised Host; D007165:Immunosuppression Therapy; D016030:Kidney Transplantation; D008297:Male; D008590:Meningoencephalitis / Q000134:cerebrospinal fluid* / Q000188:drug therapy / Q000276:immunology; D009593:Nitroimidazoles / Q000627:therapeutic use; D012008:Recurrence; D014344:Trypanocidal Agents / Q000627:therapeutic use; D014349:Trypanosoma cruzi / Q000302:isolation & purification*
D009593:Nitroimidazoles; D014344:Trypanocidal Agents; C009999:benzonidazole